Aims To investigate alterations in walking strategy and dynamic sway (unsteadiness) in people with impaired glucose tolerance and people with Type 2 diabetes in relation to severity of neuropathy and vitamin D levels.
Introduction
Walking impairment is perceived to be a late complication of diabetes, as it has been described primarily in people with established neuropathy [1, 2] ; however, a number of studies have shown walking impairment in people with diabetes before the onset of large-fibre neuropathy [3] [4] [5] [6] . This suggests that either neuropathy may not be the only contributor to this abnormality or that small-rather than large-fibre neuropathy may be a contributing factor.
Peripheral neuropathy may result in biomechanical alterations in walking and balance, with an increased risk of falls [1] [2] [3] . People with diabetes have reduced ankle and knee joint strength and power during walking as a result of distal muscular weakness [1] . Muscle weakness and alterations to muscle structure may lead to altered walking ability even in people without diabetic neuropathy [3] . Slower walking speed, shorter step length and wider step width have all been demonstrated in people without diabetic neuropathy [4] [5] [6] , and we have recently shown reduced lower limb strength and altered muscle structure in people with Type 2 diabetes and minimal neuropathy [7] .
Increased dynamic medio-lateral sway leading to unsteadiness has been reported in people with diabetic neuropathy [8] . Neuropathy can impair lower extremity function [9] , and loss of vibration perception correlates with impaired dynamic medio-lateral sway in people with diabetes [8] .
Impaired glucose tolerance may result in small-fibre neuropathy [10] and impaired standing balance and trunk position sense [11] . Furthermore, we have recently shown that distal lower limb muscle strength is reduced in participants with IGT, which could affect gait and stability during normal walking [12] .
Muscle weakness, impairment of balance and an increased risk of falls have been associated with vitamin D deficiency during upright quiet standing and walking in healthy elderly participants [13] . Vitamin D deficiency can cause proximal muscle weakness, impaired dynamic sway during walking and an increased risk of falls [14] and, of course, reduced daily activity may lead to obesity and vitamin D deficiency [15] .
The objectives of the present study were: (1) to investigate differences in walking characteristics and dynamic sway among people with IGT, Type 2 diabetes and a healthy control group and (2) to quantify the relationships among walking characteristics, neuropathy and vitamin D levels.
Methods

Participants
A total of 20 people with Type 2 diabetes (eight with mild neuropathy and 12 without neuropathy) with a median and range duration of diabetes 14 and 36 years, respectively, 20 people with IGT (10 with and 10 without neuropathy) and 20 people without IGT or diabetes (control group) underwent assessment at the gait laboratory of the Manchester Metropolitan University. The study was approved by the UK National Health Service (NHS) ethics committee, local Research Ethics Committees at the University of Manchester and the Manchester Metropolitan University. Written informed consent was obtained from all participants.
Assessment of neuropathy
Symptoms of diabetic peripheral neuropathy were assessed using the Neuropathy Symptom Profile. Neurological deficits were evaluated using the simplified neuropathy disability score, comprising assessment of vibration perception threshold, pin-prick, temperature sensation and ankle reflexes. Diabetic sensorimotor polyneuropathy was defined according to the Toronto criteria [16] . The control participants underwent assessment of vibration perception threshold and neuropathy disability score to confirm the absence of neuropathy.
Small-fibre neuropathy was evaluated by quantifying corneal nerve fibre density, corneal nerve branch density, corneal nerve fibre length, corneal nerve fibre tortuosity and intraepidermal nerve fibre density in skin biopsies from the dorsum of the foot [17] .
Gait analysis
Participants walked at their self-selected speed over a 10-m level ground walkway, stepping onto two of the three ground-embedded force platforms (Kistler, Winterthur, Switzerland), sampling at 1000 Hz. Participants' movement was assessed using a 10-camera motion-capture system (Vicon, Oxford, UK), sampling at 100 Hz. Using a full-body modified Helen-Hayes marker set, 52 reflective markers were firmly fixed onto specific anatomical landmarks of each participant's body (upper and lower body segments). Participants walked in standardized shoes appropriate for people with diabetes (MedSurg; Darco, Raisting, Germany) to control footwear condition and ensure that particpants with diabetes walked with appropriate footwear. The mean data from four walking trials containing two force platform strikes with the left foot and two with the right foot were selected for analysis.
Gait measurements
Ankle joint strength and power (peak values) during walking and temporal-spatial measurements (walking speed, step width and step length) were quantified for each participant using Visual 3D software (C-motion Inc., Germantown, MD, USA), by combining the force and motion data.
Dynamic sway during walking
Dynamic sway is the term used hereafter to define the separation distance between the body centre of mass and What's new?
• There are no previous studies comparing alterations in walking strategy and dynamic sway during walking in people with impaired glucose tolerance and Type 2 diabetes.
• Distal muscle power and speed during walking were lower in people with Type 2 diabetes compared with a control group.
• People with impaired glucose tolerance but not those with Type 2 diabetes had a significantly higher dynamic medio-lateral sway during walking.
• Early alterations in dynamic sway during walking were associated with small-but not large-fibre neuropathy.
• Vitamin D levels were not associated with alterations in walking strategy and dynamic sway in people with impaired glucose tolerance or those with Type 2 diabetes.
centre of pressure during walking in two planes: a frontal plane (medio-lateral dynamic sway) and a sagittal plane (anterior-posterior dynamic sway; Fig. 1 ).
Statistical analysis
A one-way ANOVA with post hoc Bonferroni was used to test the differences among the three independent study groups (Type 2 diabetes, IGT and control groups) for the measured variables. An independent samples Student's t-test was used to assess differences between two groups for specific categories of variables: differences in walking and dynamic sway variables between people with and without neuropathy and with lower and higher values of vitamin D [25(OH)D <25 nmol/l vs >25 nmol/l]. Pearson's correlation coefficient was used to assess the correlation between walking and dynamic sway variables. All data are expressed as mean AE sd, unless otherwise stated. The statistical power for the majority of walking and dynamic sway measurements in participants with IGT and those with Type 2 diabetes was 0.8-1.0 (Table 2) , which is very high considering the optimum recommendation is 0.8 [18] . We performed an a priori power calculation based on ankle joint strength (torque) from a previous study [19] . The power analysis indicated that we needed 14 participants in each group to detect a difference of 22 Nm between groups (~20% difference between groups), with an a level of 0.05 and a b level of 0.9 (i.e. power of 90%). To account for dropouts we recruited 20 participants into each group and we also adopted a more stringent a level (P < 0.01).
Results
Clinical assessment
A total of 20 healthy control participants (13 men and seven women, two Asian and 18 European), 20 participants with IGT (16 men and four women, five Asian and 15 European) and 20 participants with Type 2 diabetes (15 men and five women, nine Asian and 11 European) were assessed. Participants were well matched for age and height, but body mass (P = 0.006) and BMI (P = 0.01) were significantly higher in participants with IGT compared with control participants. HbA 1c levels were significantly higher in participants with IGT and particpants with Type 2 diabetes compared with control particpants. 25(OH)D levels did not differ significantly among the groups (Table 1) .
Neuropathy assessments
Vibration perception threshold was significantly higher in participants with IGT (P = 0.001) but not in those with Type 2 diabetes (P = 0.02) compared with the control group. Neuropathy disability score did not differ significantly between participants with IGT (P = 0.02) and those with Type 2 diabetes (P = 0.04), but was higher compared with control participants. Peroneal and sural nerve conduction velocity and amplitudes did not differ among the groups. Corneal nerve fibre density was significantly lower in participants with IGT (P = 0.004) and participants with Type 2 diabetes (P = 0.004) compared with control participants. Corneal nerve branch density was significantly lower only in participants with IGT (P = 0.002) compared with control participants. Corneal nerve fibre length, corneal nerve fibre tortuosity and intraepidermal nerve fibre density did not differ among the groups (Table 1) .
Peak ankle joint strength and power during walking During walking, peak ankle plantar flexion strength (P = 0.01) and power (P = 0.003) were significantly lower in participants with Type 2 diabetes compared with control participants (Table 2) .
Temporal-spatial gait measurements
Participants with Type 2 diabetes had a significantly slower walking speed (P = 0.008) compared with control participants. There was no difference in step length among the FIGURE 1 Calculation of dynamic sway. Dynamic sway (S), defined as the separation of the body centre of mass (grey circle) and the centre of pressure (grey triangle). Dynamic sway is shown in the sagittal (left image) and frontal (right image) planes, illustrating the separation in the anterior-posterior direction and medial-lateral directions, respectively. Also highlighted in the sagittal plane image is the resultant ground reaction force vector (grey arrow) and the ankle joint centre position (black cross); joint moments (strength) were calculated based on the relative position and magnitude of the ground reaction force from the joint centre, as well as taking into account the mass and acceleration of the relevant body segments.
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Dynamic sway
During walking, dynamic medio-lateral sway (P = 0.007) was higher and posterior maximal movement (P = 0.000) was lower in participants with IGT compared with control participants (Table 2) .
Peripheral neuropathy vs no peripheral neuropathy
There were no significant differences in ankle plantar flexion strength (1.1 AE 0.1 vs 1.2 AE 0.1 Nm/kg; P = 0.87) and power (2.5 AE 0.6 vs 2.6 AE 0.7 Watts (W)/kg; P = 0.54), walking speed (1.3 AE 0.2 vs 1.3 AE 0.2 m/s; P = 0.77), step width (13.0 AE 2.8 vs 11.7 AE 2.6 cm; P = 0.11), step length (148.4 AE 17.9 vs 140.1 AE 19.9 cm; P = 0.11) and dynamic medio-lateral sway (14.9 AE 8.0 vs 13.4 AE 4.3 cm; P = 0.46) in participants with (n = 19) compared with participants without (n = 41) peripheral neuropathy.
Low vs normal vitamin D levels
During walking, there was no significant difference in ankle plantar flexion strength (1.1 AE 0.1 vs 1.2 AE 0.1 Nm/ kg; P = 0.22) and power (2.3 AE 0.5 vs 2.6 AE 0.74 W/kg; P = 0.12), walking speed (1.4 AE 0.2 vs 1.3 AE 0.2 m/s; P = 0.13), step width (12.1 AE 1.8 vs 12.1 AE 2.8 cm; P = 0.92) and dynamic medio-lateral sway (9.7 AE 3.9 vs 8.4 AE 3.8 cm; P = 0.36), but step length (70.5 AE 10.3 vs 
Correlations
There were low to moderate correlations between dynamic medio-lateral sway with corneal nerve fibre length (r = 0.406; P = 0.001) and corneal nerve branch density (r = 0.436; P = 0.001), but no significant correlation with vibration perception threshold (r = 0.17; P = 0.19).
Discussion
This is the first study to show an early alteration in the natural walking strategy and dynamic sway in people with IGT, which was similar to that in people with Type 2 diabetes. This challenges the belief that balance impairment during walking only occurs in people with diabetes and advanced large-fibre neuropathy [8] . Furthermore, we show that small-rather than large-fibre abnormalities are more strongly associated with balance impairment. Whilst the present results confirm previous findings of a reduction in ankle joint strength and power during walking in people with Type 2 diabetes [20, 21] , we also showed that participants with IGT had a reduction in ankle joint power during walking. These findings are supported by our recent data showing a significant weakness of the distal ankle plantar flexors in people with Type 2 diabetes [7] and people with IGT [12] .
It has previously been shown that people with diabetic neuropathy have a slower self-selected walking speed, smaller step length and greater step width compared with a control group [3, 20] . In the present study, whilst walking velocity, stride length and step length were preserved, the step width was greater in participants with IGT, suggesting that this may be an early defect. Previously, we have observed a greater step width in people with severe diabetic neuropathy compared with a control group [8] . This was not found in participants with diabetes in the present study as they had only mild neuropathy; however, the IGT group with an equivalent severity of neuropathy adopted an increased step width, which may be attributable to the greater BMI in this group. Indeed, whilst a greater step width has been traditionally regarded as a way for people with diabetes to increase their base of support [22] , we recently reported a positive correlation between step width and medio-lateral dynamic sway [8] ; thus, increased step width may be an early sign of walking impairment in people with IGT, representing a more 'cautious' walking strategy commonly observed in people with diabetic neuropathy [5, 20] .
The lower ankle strength and power observed during walking in participants with IGT and diabetes may be one of the main underlying factors explaining the slower walking speed, particularly ankle power, which reflects aspects of both force and speed [2, 8, 20, [23] [24] [25] . The slower walking speed observed in participants with IGT and participants with Type 2 diabetes may well be a compensatory strategy to lower the strength demands of walking, as reported in previous studies in people with diabetes [26] . Furthermore, the reduced step length observed in participants with IGT and Type 2 diabetes in the present study constitutes a 'biomechanical strategy' that helps to reduce the strength required from knee and ankle muscles by reducing the flexion (and therefore the required torque) of these joints.
Reduced ankle strength and power during walking may play a role in unsteadiness, which can be quantified by measuring dynamic medio-lateral sway. Indeed, we have found that dynamic medio-lateral sway was already higher in participants with IGT during walking, indicating greater unsteadiness, consistent with our recent findings in people with diabetic neuropathy [8] . This is also consistent with previous findings of impaired postural sway during upright standing balance tests in participants with IGT [11] . In the present study, we observed a higher mean dynamic mediolateral sway in participants with IGT, which means on average they showed more side-to-side sway, whereas people with Type 2 diabetes showed a greater range of dynamic medio-lateral sway, indicating that they periodically allowed greater side-to-side sway and more variability, creating a more 'dangerous' situation in terms of the risk of falling for the group with Type 2 diabetes. Diabetic neuropathy may have a negative impact on balance during walking [8, 25, 27] and, indeed, a recent study has shown that people with diabetic neuropathy have a disturbance in postural sway during upright standing [28] . The presence of peripheral neuropathy may be a potential explanation for the increased medio-lateral sway observed in participants with IGT in the present study, however, our study participants had minimal evidence of large-fibre neuropathy. Traditionally, it has been suggested that quite marked impairment in sensation and proprioception is required to cause walking alterations [2, 20, 23, 25, 29] ; however, we now show significant alterations with minimal evidence of large-fibre neuropathy.
We have previously shown an association between loss of vibration perception and dynamic medio-lateral sway during walking in people with diabetes [8] but, in the present study we did not observe a correlation between vibration perception threshold and medio-lateral sway, possibly because the majority of people with diabetes had very minimal large-fibre neuropathy. A novel finding in the present study, however, is the much stronger association between dynamic sway and small-fibre neuropathy determined using corneal confocal microscopy. The mechanistic basis for the association ª 2017 Diabetes UK between dynamic sway and small-fibre pathology requires further study, especially as there was no association with intraepidermal nerve fibre density in the foot. We have also shown that participants with IGT have smaller dynamic anterior-posterior sway, which reflects the shorter step length taken by participants with IGT and was similar to previous studies in people with diabetes [5, 8, 20] . The smaller posterior maximum anterior-posterior sway is probably explained by participants with IGT not allowing their body centre of mass to remain as far back compared with the control and Type 2 diabetes groups when transferring over to the leading leg during walking; this is probably because the joint moments (strength) associated with keeping the centre of mass any further back would be very high as a result of the flexed joints and high body mass of the IGT group.
Severe vitamin D deficiency is related to postural instability during quiet standing and to an increased risk of falls in elderly people [30] . In the present study, however, our participants did not have severe vitamin D deficiency, and we therefore compared low with relatively normal levels of vitamin D and found no relationship with walking strategy or unsteadiness. This finding is consistent with our recent finding that people with Type 2 diabetes had a significantly reduced lower limb muscle strength, which was related to the severity of neuropathy but not to the level of vitamin D [7] . Although, in people with IGT we have recently shown a significant reduction in distal muscle strength, which was associated with increased intramuscular non-contractile tissue, small-fibre neuropathy and vitamin D deficiency [12] .
Vitamin D deficiency affects proximal more than distal muscles of the lower limb [13, 20] . The present study found that people with Type 2 diabetes and low vitamin D levels had significantly higher dynamic medio-lateral sway compared with those with adequate levels of vitamin D, suggesting that vitamin D deficiency may play a role in balance impairment in people with Type 2 diabetes. Previously healthy participants with severe vitamin D deficiency (<25 nmol/l) have been shown to have decreased proximal muscle strength, increased postural sway during quiet standing and an increased risk of falls [31] .
We acknowledge that the present study was undertaken with a small sample of people with a relative imbalance of ethnicities and did not include people with severe diabetic neuropathy or vitamin D deficiency, which may limit translation to the general population with IGT and Type 2 diabetes. Furthermore, the assessment of walking strategy in a more challenging environment, such as on stairs, may have enhanced the clinical relevance of our findings.
In conclusion, biomechanical changes to the natural walking strategy and balance control during walking occur in people with IGT and Type 2 diabetes, and are related to small-fibre neuropathy but not to vitamin D deficiency. Larger, longitudinal studies are required to better understand the evolution and consequences of these abnormalities.
